Novel interactions between the C5 ‐ C5aR 1 Axis and IF 1: Implications for kidney mitochondrial physiology and ischemia–reperfusion injury
Physiological Reports · 2026-06 · 14 (11)
DOI: 10.14814/phy2.70942 ↗At a glance
Journal article in Physiological Reports, published online on 2026-05-29. Written by Madison McGraw and 5 co-authors. Institution: Department of Pharmacology & Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. Major MEDLINE topics: Receptor, Anaphylatoxin C5a, Reperfusion Injury, Mitochondria, Kidney. Cited 1 times so far (Crossref); 124 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIDDK NIH HHS, American Heart Association (AHA), National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (original language)
Ischemia‐reperfusion injury (IRI) is a prevalent condition that predominantly afflicts hospitalized patients, inducing acute kidney injury (AKI). In recent years, complement 5 (C5) and its anaphylatoxin receptor C5aR1 have been implicated in driving kidney IRI and loss of function. Beyond this, prior studies suggest C5‐C5aR1 mediates mitochondrial ROS production, although its role in the mitochondria has never been fully characterized. Here, we leverage a previously generated model of C5 gene deletion (male C5 −/− rats) and the clinically relevant C5aR1 inhibitor Avacopan (AV) to investigate C5‐C5aR1 signaling in renal mitochondrial physiology and pathophysiology. For the first time, we report that C5‐C5aR1 axis inhibition modifies physiological mitochondrial protein levels, respiratory activity, and complexes/supercomplexes. We identified a novel relationship between the C5‐C5aR1 axis and ATPase Inhibitory Factor 1 (IF1), a potent regulator of the ATP synthase, using in vivo and in vitro approaches. Post‐IRI, C5‐C5aR1 axis inhibition improved kidney function/morphology and preserved ATP levels, despite IRI‐mediated disintegration of mitochondrial complexes and supercomplexes. We show in vitro that C5‐C5aR1 axis inhibition facilitated IF1‐dependent ATP recovery via the glycolysis pathway. Collectively, our results demonstrate a complex interplay between C5‐C5aR1 and IF1 in renal mitochondria, which contributes to mitochondrial pathophysiology during IRI.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacology & Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
ORCID profiles: Madison McGraw, Nirmala Parajuli
Funding
- NIDDK NIH HHS
- American Heart Association (AHA)
- National Institute of Diabetes and Digestive and Kidney Diseases
Cite
APA
McGraw, M., Sharma, A., Bhattarai, D., Gokden, N., Macmillan-Crow, L., & Parajuli, N. (2026). Novel interactions between the C5 ‐ C5aR 1 Axis and IF 1: Implications for kidney mitochondrial physiology and ischemia–reperfusion injury. Physiological Reports, 14(11). https://doi.org/10.14814/phy2.70942
Vancouver
McGraw M, Sharma A, Bhattarai D, Gokden N, Macmillan-Crow L, Parajuli N. Novel interactions between the C5 ‐ C5aR 1 Axis and IF 1: Implications for kidney mitochondrial physiology and ischemia–reperfusion injury. Physiological Reports. 2026;14(11). doi:10.14814/phy2.70942
BibTeX
@article{McGraw2026,
author = {McGraw, Madison and Sharma, Amod and Bhattarai, Dinesh and Gokden, Neriman and Macmillan-Crow, LeeAnn and Parajuli, Nirmala},
title = {Novel interactions between the C5 ‐ C5aR 1 Axis and IF 1: Implications for kidney mitochondrial physiology and ischemia–reperfusion injury},
journal = {Physiological Reports},
year = {2026},
volume = {14},
number = {11},
doi = {10.14814/phy2.70942}
}
EUVIMED